PosterSessionOnline

EUROPEAN ALLIANCE OF ASSOCIATIONS FOR RHEUMATOLO..

EULAR 2025

11-14 June 2025 Barcelona

N. Poster

Poster title

Applicant name

Status


3-POS	Specific targeting of the 5-hydroxytryptamine 2B receptor (5-HT2BR) demonstrates antifibrotic effects in murine models and ex vivo models of scleroderma skin	Thuong Trinh-Minh	Received

9-POS	Early Onset and Durability of Efficacy in Inebilizumab-treated Participants with IgG4 Related Disease: Post Hoc Analyses from the Phase 3 MITIGATE Trial	John H. Stone	Received

12-POS	Selective inhibition of TNFR1 signal by balinatunfib in vitro does not inhibit Treg expansion in contrast to anti-TNF biologics inhibiting TNFR1 and TNFR2 signaling	Himanshi Bhatia	Received

16-POS	Characterization of ORKA-002, a Novel Extended Half-life Monoclonal Antibody Targeting IL-17A/F for the Treatment of Psoriasis and Psoriatic Arthritis	Shauna Jardon	Received

21-POS	Prevalence, clinical correlations and outcomes of Cryoglobulinemic Vasculitis: a retrospective monocentric study (20132023)	Luca Quartuccio	Received

24-POS	Different pattern of ANCA-associated vasculitis in the elderly - data from Polish National Registry (POLVAS)	Anna Masiak	Received

31-POS	Exploring the Potential for Cardiorenal-Metabolic Therapies to Target Comorbidities in Early Rheumatoid Arthritis	Bindee Kuriya	Received

40-POS	Pathological contributors to organ damage and mortality in systemic sclerosis: a Nationwide matched case-control study	Jessica Fairley	Received

42-POS	Epidemiological Analysis of Systemic Sclerosis Prevalence and Survival in Israel Using the Clalit Health Services Database: Geographic Distribution, Demographics, and Mortality Trends	Amir Bieber	Received

52-POS	Real-World Insights into the Treatment Satisfaction and Unmet Needs of Sjögrens Disease: A Patient-Centered Analysis	Thom Dewar	Received

53-POS	Clinical trial participation in Sjogrens disease	Joe Berry	Received

56-POS	CNTY-101, an iPSC-Derived Allogeneic CD19 Targeting CAR-NK Product, Exhibits Robust B Cell Depletion and Has Broad Potential for Development in B Cell-Driven Autoimmune Diseases	Hongxia Zhang	Received

68-POS	Polygenic risk scores improve risk assessment of cardiometabolic comorbidities in patients with rheumatoid arthritis	Hanna-Kaisa Aaramaa	Received

70-POS	Specific synovial tissue macrophage cluster subtypes are associated with multi-biologic refractoriness in rheumatoid arthritis	Pedro Martínez-Paz	Received

72-POS	Targeting neutrophil cytoskeletal dysregulation in ANCA Associated Vasculitis	Noelle Pisacano	Received

75-POS	Neutrophil Mitochondrial Capacity is altered in vitro in ANCA Associated Vasculitis	Noelle Pisacano	Received

79-POS	Spatial Transcriptomics Reveal the Role of MMP12 in the Pathogenesis of Giant Cell Arteritis	Shinichi Onishi	Received

80-POS	Mass cytometry of polymyagia rheumatica shoulder bursa biopsy reveals activation and pro-inflammatory cytokine expression by B cells and plasmacells.	Guillermo CARVAJAL ALEGRIA	Received

87-POS	OVERLAP SERONEGATIVE SYNDROME OF AUTOIMMUNE HEPATITIS AND PRIMARY BILIARY CHOLANGITIS IN A PATIENT WITH SCLERODERMA.	Víctor Iván Hernández Sánchez	Received

94-POS	Pharmacodynamic Activity of JNJ-67484703 in Rheumatoid Arthritis, Ulcerative Colitis and Sjogrens disease (PARIS): Results of a Phase II Proof of Biology Trial	Benjamin Fisher	Received

95-POS	Safety and Outcomes of Biological Disease-Modifying Antirheumatic Drugs in Patients Undergoing Dialysis: A Large-Scale Retrospective Analysis	Elia Touma	Received

102-POS	ADALIMUMAB vs. IXEKIZUMAB EFFECTIVENESS IN PATIENTS WITH PSORIATIC ARTHRITIS: A REAL-WORLD MULTICENTER STUDY WITH MATCH-ADJUSTED COMPARISONS	Valentino Paci	Received

105-POS	DUAL INHIBITION OF IL-17A AND IL-17F WITH BIMEKIZUMAB DEMONSTRATED LONG-TERM SAFETY AND EFFICACY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO TUMOUR NECROSIS FACTOR INHIBITORS: FINAL 3-YEAR RESULTS FROM THE PHASE 3 BE COMPLETE STUDY AND ITS OPEN-LABEL EXTENSION	Bethan Taylor	Received

106-POS	Real-World Treat-to-Target Strategy in Psoriatic Arthritis: 48-week Results from the MONITOR-PsA Cohort	Jean-Guillaume Letarouilly	Received

108-POS	Global Recruiting Patterns are Associated with Placebo Response Rates in Clinical Trials of Psoriatic Arthritis	Andreas Kerschbaumer	Received

113-POS	Factors Associated with Response to IL23 Inhibitors in Axial and/or Mixed Psoriatic Arthritis: A Multicenter Observational Study (APxis-IL23)	RAQUEL ALMODOVAR	Received

117-POS	Identification of Risk factors for Difficult-to-Treat Ankylosing spondylitis to enhance risk Stratification	Marina Magrey	Received

128-POS	HOW SYMPTOMATIC IS DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS A COMPARATIVE STUDY OF CLINICAL, FUNCTIONAL AND QUALITY OF LIFE OUTCOMES WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS (REGISPONSER REGISTRY).	Clavaguera Teresa	Received

129-POS	Whole-body SPECT-CT CzT-based camera (Veriton-CT) versus MRI in the assessment of sacroiliitis in spondyloarthritis patients	Mathilde FIORINO	Received

136-POS	Impact of a Rapid Access Clinic on Referrals, Diagnosis and Prednisolone Initiation in Suspected Polymyalgia Rheumatica	Elisabeth Nielsen	Received

137-POS	The OMERACT Giant Cells Arteritis Ultrasonography Score (OGUS) is associated with atherosclerosis in healthy individuals, and does not improve the diagnostic performance of giant cell arteritis compared to the bilateral halo sign, halo count, and halo score	Simon CADIOU	Received

141-POS	Application of Artificial Intelligence Tools in Axial Spondyloarthritis Imaging Assessment: a Systematic Literature Review Evaluating the Performances across MRI, CT, and Radiography	Emilia Gvozdenovic	Received

154-POS	Comparative Safety Outcomes of Tofacitinib Versus Upadacitinib in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study	Maya Khasho	Received

159-POS	Positivity for antinuclear antibodies in seronegative early rheumatoid arthritis identifies a subgroup of patients with different clinical features and better response to conventional synthetic disease modifying anti-rheumatic drugs	Clelia Zampaglione	Received

163-POS	Anxiety at 3 Months is Associated with Worse Disease Activity, PROs, and Predicts Progression to Advanced Therapies by 12 months in Early RA: Results from the Canadian Early Arthritis Cohort (CATCH)	Susan Bartlett	Received

172-POS	Disease Coping Mechanisms and Quality of Life in Patients with Systemic Lupus Erythematosus	Shekoofeh Yaghmaei	Received

173-POS	Clinical, histological, and serological predictors of renal function loss in lupus nephritis.	Andrea Fava	Received

180-POS	Value of lung ultrasonography for screening interstitial lung disease in patients with rheumatoid arthritis	sebastien ottaviani	Received

181-POS	Does clinical and/or Ultrasound-Detected Synovitis predict Subsequent Radiographic Progression at the joint level in Patients with Rheumatoid Arthritis	Raphaël Auffret	Received

188-POS	How to score the wrist joint by ultrasound: exploration of the most sensitive joint assessment in early and established rheumatoid arthritis	Yusuke Yoshida	Received

189-POS	Patients values and needs in the diagnosis and management of axial spondyloarthritis: results from a UK-based online survey	Dale Webb	Received

191-POS	Evaluating the developmentally appropriate approach of a young adult rheumatology service: using young peoples perspectives to improve services	Rachel Nirmal	Received

198-POS	An unmet generation: How can we better support people with an RMD aged 30-45	Patricia Pennings	Received

205-POS	Sexual Health Challenges in Primary Antiphospholipid Syndrome: Exploring Prevalence and Clinical Correlates	Javier Merayo-Chalico	Received

215-POS	The role of pain catastrophizing in explaining discrepancies between tender and swollen joint counts in psoriatic arthritis.	Mateusz Wilk	Received

218-POS	Tender only joints in established rheumatoid arthritis respond to b/tsDMARD and persistent tender only joints are associated with baseline ultrasound synovitis and erosions	Irina Gessl	Received

226-POS	Birthprints: Can Perinatal Exposures Shape the Future Risk of Rheumatoid Arthritis	Perrine Dusser	Received

241-POS	The Synovial Cytokine Milieu Shapes Fibroblast-like synoviocyte-Immune Cell Interaction Driving Immune Cell Activation and Synovial Pathotype Development in Rheumatoid Arthritis	Mirjam Dellinger	Received

256-POS	Nonsteroidal Anti-Inflammatory Drug Use and Incident Hypertension among Patients with Axial Spondyloarthritis: Insights from the DESIR Cohort	Jean Liew	Received

259-POS	Comparative Efficacy of Biologics and Targeted Synthethic Therapies in Patients with Non-Radiographic Axial Spondyloarthritis: A Network Meta-Analysis	Hira Imran	Received

261-POS	Comparing Cardiovascular Outcomes in Ankylosing Spondylitis patients with and without biologics: A Retrospective Cohort Study	Justin Riley Lam	Received

264-POS	High serum levels of Vascular Cell Adhesion Molecule 1 associate with a vasculopathic phenotype in systemic sclerosis with higher mortality	Matthew Parker	Received

268-POS	Esophageal dysmotility patterns are associated with more severe features and worse outcomes in patients with Systemic Sclerosis	Luis G Alcala-Gonzalez	Received

272-POS	Increased circulating level of fatty acid-binding protein 3 (FABP3): a potential biomarker of damage in inflammatory myopathies patients	Margherita Giannini	Received

273-POS	Efficacy of Intravenous Immunoglobulin on Pulmonary Manifestations in Patients with Dermatomyositis: Post-hoc Analysis of the ProDERM data	Elisabeth Clodi	Received

274-POS	Prognostic Significance of 1-Year Pulmonary Function Changes in Myositis-Associated Interstitial Lung Disease	Shiri Keret	Received

276-POS	Janus kinase inhibitor plus protein A immunoadsorption in anti-MDA5 dermatomyositis patients with rapidly progressive interstitial lung disease	Yakai Fu	Received

281-POS	Clinical Meaningfulness and Improvement Thresholds of Myositis Core Set Measures: Association with Patient-Reported Outcomes	Shiri Keret	Received

283-POS	The role of repeat skeletal muscle biopsy: indications, yield and outcomes	Thomas Khoo	Received

299-POS	Risk analysis of clinical psoriatic arthritis development in patients with psoriasis and recent-onset arthralgia	Alen Zabotti	Received

302-POS	Development and evaluation of a machine learning model for the early identification of psoriatic arthritis in the community	Michael Dreyfuss	Received

317-POS	The immune map of lupus nephritis: a spatially-resolved kidney proteomic approach.	Andrea Fava	Received

319-POS	Improved Efficacy and Safety Outcomes in Patients with Systemic Lupus Erythematosus (SLE) Treated with Belimumab (BEL) Versus Immunosuppressants (IS), in Addition to Antimalarials (AM) and Glucocorticoids (GC): A Post Hoc Summary of Five Phase 3 Trials	Heather Dowling	Received

320-POS	Treatment with anifrolumab prevents long-term organ damage compared to real-world standard of care: Findings from the LASER study	Estefania Vazquez Mendez	Received

323-POS	Validation and Characterization of Six Distinct SLE Molecular Subtypes Using Two Large Patient Cohorts and Multi-Omics Platforms	Matthew J Loza	Received

328-POS	Efficacy and Safety of Avacopan for Treatment of Patients with ANCA-Associated Vasculitis Receiving Cyclophosphamide	Rachel Gurlin	Received

329-POS	Recent glucocorticoid-sparing strategies lead to better prognosis for ANCA-associated vasculitis: Insights from the multicenter REVEAL cohort study	Mayu Shiomi	Received

346-POS	Structured Patient Involvement in RMD Research: Identifying and ranking 20 Key Research Questions from patients using the James Lind Alliance method	Anna Fryxelius	Received

366-POS	Prognostic Value Of Hyperuricemia In Developing Cardiovascular Events In Patients With Chronic Inflammatory Arthritis: A 10-Year Prospective Study.	Antonio Avilés	Received

374-POS	Clinical Impact of Signs of Calcium Pyrophosphate Deposition Disease (CPPD) on Radiographs of Hands and Wrists in a Real-World Cohort of Patients with Early Rheumatoid Arthritis	Coralie Tremblay	Received

379-POS	PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome	Kathleen York	Received

380-POS	Spanish iMCD registry Epidemiology of idiopathic multicentric Castleman disease in Spain (ARCANA) - Prevalence Cohort	Andrés González García	Received

381-POS	Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI)	Kathleen York	Received

382-POS	The CARDIOSTILL Study: A French Observational Retrospective Study on Cardiac Involvement in Adult Stills Disease.	Nadine SOLIMAN	Received

384-POS	Pulmonary arterial hypertension with Stills disease: a new pulmonary manifestation associated with HLA-DRB1*15	Stéphane Mitrovic	Received

387-POS	Neutrophil extracellular traps accelerate cytokine storm in autoimmune and autoinflammatory disease by promoting STING-mediated myelopoieis	Jinchao Jia	Received

390-POS	Delay in consolidation and prevalence of pseudoarthrosis in patients undergoing treatment with Zoledronic Acid during hospitalization for osteoporotic fracture in a FLS	María Isabel Prado Carpintero	Received

395-POS	Safety and Efficacy of Romosozumab in Real-World practice: Experience in a Tertiary Care Hospital	Cristina Valero Martínez	Received

407-POS	Gender specific differences in rheumatologists reasons to shift from hospital to private practice - findings from a survey across Europe	Judith Sautner	Received

412-POS	Investigation of Subsequent Inflammatory or Autoimmune Diagnoses Following Initial RMD Diagnosis	Kaleb Michaud	Received

415-POS	Developing a Rehabilitation Registry in Rheumatology: From Core Set Selection to Future Applications	Alice Ashouri Christiansen	Received

419-POS	Underestimated Impact of Disease Duration on Health-Related Quality of Life in Hip Osteoarthritis: Insights from the Austrian Better Life in Osteoarthritis Registry	Valentina Schmolik	Received

420-POS	Association Between Plant-Based Diet Indices and Incident Arthritis Among Older Chinese Adults: A Ten-Year Prospective Nationwide Cohort Study	Aijing Liu	Received

422-POS	The Bravery Book: Malus Fantastic Hats for Dreadfully Annoying Rheumatism Days - An encouraging and educational book with accompanying material for children with rheumatism.	Caroline Kirsten	Received

434-POS	Is Methotrexate Tapering Possible In Stable RA Clinical Observations of Methotrexate Tapering At Two Tertiary Care Centers	Tarun Sharma	Received

447-POS	Real-World Insights into the Burden of Sjögrens Disease: A Patient-Centered Analysis	Thom Dewar	Received

451-POS	A Phase 1b, Randomized, Double-Blinded, Placebo-Controlled Dose Ranging Study to Evaluate the Safety, Tolerability and Pharmacodynamics of a Single Intra-articular Injection of GNSC-001 Gene Therapy in Subjects with Osteoarthritis of the Knee (DONATELLO):	Jeyanesh Tambiah	Received

456-POS	ERIN - Registry for the Documentation of Rheumatic Immunotherapy-Related Adverse Events	Didzis Gailis	Received

457-POS	Swollen joints and assessors global, but not tender joints and patients global, predict power Doppler remission in established RA	Hilde Berner Hammer	Received

459-POS	Patients Perspective toward Rheumatic and Musculoskeletal Diseases: Insights from a Large-Scale Survey	Khalid A. Alnaqbi	Received

460-POS	Pediatric ANCA-Associated Vasculitis Study of Avacopan Efficacy, Pharmacokinetics, and Safety: A Phase 3 Trial in Progress	Hilary Durbano	Received

461-POS	Characterization of patients with rheumatoid arthritis based on distinct patterns of pain improvement following treatment with filgotinib: A post hoc analysis of FINCH 1	Ilona Swiatkowska	Received

464-POS	Comparative Study of Glucocorticoid Tapering Strategies in Patients with ANCA-Associated Vasculitis Receiving Rituximab for Remission Induction: An International Multicenter Cohort Study	Ryo Yanai	Received

465-POS	Large-scale real-world data depicts the complexity of DMARDs treatment sequences in rheumatoid arthritis	Marina Colombo	Received

471-POS	Damage Assessment in Primary Sjogrens Syndrome	Ana Mafalda Abrantes	Received

476-POS	Analysing the Economic Impact of Denosumab in the Treatment of Osteoporosis	Nathashi Jayawardena	Received

490-POS	Challenges in implementing evidence-based health interventions in the European Union: the role of the contextual analysis in the SQUEEZE Project	Estibaliz Loza Santamaría	Received

503-POS	High activity of factor XI and C1 inhibitor in patients with ANCA-associated vasculitis may be related to an increased risk of thrombotic events a preliminary study	Rados&322;aw Dziedzic	Received

507-POS	Randomized Control Trial of the CARE RA Peer Coach Intervention to Improve Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis	Vanessa madrigal	Received

514-POS	Long-term use of glucocorticoids in people with rheumatoid arthritis: a Cochrane living systematic review	Samuel Whittle	Received

515-POS	Eosinophilic Cardiomyopathy and its Critical Impact on Cardiac Function: Prognostic Value of NT-proBNP and Left Ventricular Ejection Fraction	Fabian T. H. Ullrich	Received

516-POS	Applicability of the phase 3 Trial DAISY (Determine effectiveness of Anifrolumab In SYstemic Sclerosis) inclusion criteria to the general SSc population a study from the EUSTAR cohort.	Emily Kaye	Received

518-POS	Baseline levels of angiopoietin-1, IL-17A, and osteopontin may help differentiate subclinical GCA in PMR from pure PMR.	Sharon Cowley	Received

520-POS	Discontinuation vs. continuation of concomitant methotrexate in patients with rheumatoid arthritis on certolizumab pegol: Results from a randomized, controlled trial	Shuji Asai	Received

521-POS	Association between nutritional status and frailty in patients with rheumatoid arthritis from a multicenter observational study (T-FLAG study)	Mochihito Suzuki	Received

522-POS	Analysis of the impact of affected joint distribution on global pain in patients with rheumatoid arthritis (RA) based on a nationwide RA database in Japan	Shigemoto Igari	Received

537-POS	Data-driven clustering approach to identify different phenotypes of primary central nervous system vasculitis	Hubert de Boysson	Received

542-POS	AvacoStar, a real-world evidence study of avacopan in ANCA-associated vasculitis baseline characteristics of initial patients	Donna Kennedy	Received

544-POS	Age of Disease Onset and Risk of Serious Infection with anti-TNF Use in Older Adults with Rheumatoid Arthritis	Jiha Lee	Received

545-POS	Retrospective analysis of cardiovascular and malignancy risk factors in real world JAK inhibitor cohort and the effects of UK regulatory agency guidance cautioning JAK inhibitor use on prescribing.	John Fitton	Received

552-POS	Implementing a Digital Platform for Real-Time Collection and Integration of Patient-Reported Insights in Rheumatic Disease Management	David Curtis	Received

557-POS	Improving Systemic Sclerosis Quality of Care. An Interrupted Time Series Quality Improvement Study	Aos Aboabat	Received

558-POS	EULAR Classification Criteria for Haemochromatosis Arthropathy	Patrick Kiely	Received

562-POS	Evaluation of Small bowel Involvement in Systemic Sclerosis Using Morpho-Functional Image Analysis Assisted by Artificial Intelligence	Luis Gerardo Alcala-Gonzalez	Received

564-POS	Self-reported oropharyngeal dysphagia and swallowing-related quality of life in people with systemic sclerosis: preliminary results of a cross-sectional study	Devis Benfaremo	Received

565-POS	Overview of authorised drugs to be repurposed for the treatment of osteoarthritis: a scoping review of clinical studies	Michelle Heijman	Received

569-POS	Early Access Program (EAP) of Avacopan for the Treatment of ANCA-Associated Vasculitis (AAV): The Italian Multicenter Prospective Real-World Experience Beyond 52 Weeks	Luca Quartuccio	Received

578-POS	Real-world effectiveness of filgotinib in patients with rheumatoid arthritis treated for up to 2 years in clinical practice: Interim results from FILOSOPHY and PARROTFISH	Ilona Swiatkowska	Received

580-POS	Relationship between mHAQ items and fractures in patients with rheumatoid arthritis	Yumi Arai	Received

584-POS	Overall safety profile and laboratory parameters in patients with rheumatoid arthritis treated with filgotinib for up to 2 years: Real-world evidence from FILOSOPHY and PARROTFISH	Ilona Swiatkowska	Received

590-POS	Characterization of improvements in pain, HAQ-DI, and radiographic and long-term safety outcomes in distinct CDAI trajectory groups of patients with rheumatoid arthritis treated with filgotinib: A post hoc analysis of FINCH 1	Ilona Swiatkowska	Received

594-POS	Double Positivity for Anti-Ro52/TRIM21 and Anti-Ro60/SSA Antibodies is Linked to Greater Organ Involvement and Disease Progression in Systemic Sclerosis: Insights from the Renji Scleroderma Longitudinal Cohort	Wanyi Lin	Received

595-POS	Impact of Hydroxychloroquine on Mortality and Cardiovascular Outcomes in Systemic Sclerosis: A Retrospective Cohort Study	Shahrzad Abdollahi	Received

597-POS	Safety, Tolerability, and Activity of JNJ-67484703 in Participants with Active Rheumatoid Arthritis: Results of a Multicenter, Double-blind, Placebo-controlled, Randomized, Multiple-dose Phase 1b Study	Erika Noss	Received

604-POS	Comparing avacopan use in patients with GPA during induction phase with Rituximab and prednisone: A retrospective study using the TriNetx database	Shahrzad Abdollahi	Received

607-POS	Quantifying tissue microstructural changes in scleroderma skin using a novel, point-of-care, high-frequency-ultrasound instrument	Kimberly Lakin	Received

611-POS	One year persistence and effectiveness of guselkumab or TNFi as second-line treatment after receiving a TNFi as first-line therapy to treat active psoriatic arthritis: MANHATTAN study	Carolina Munoz	Received

612-POS	How do we predict treatment response in Osteoarthritis Analysis of a cohort study in people with knee Osteoarthritis	Alistair Paterson	Received

627-POS	Examination of Clinical Outcomes by Treatment Duration of Biologics and JAK inhibitors in Nonagenarian Rheumatoid Arthritis	Kou Katayama	Received

631-POS	Clinical and economic hospital burden and care pathways of patients with ANCA-associated vasculitis in Italy: an administrative data-driven analysis.	Hannah Woodley	Received

632-POS	Are genes in T-regulatory cells are differentially following treatment with allogeneic mesenchymal stem cells in early RA	Nora Singer	Received

633-POS	OLOKIZUMAB IMPROVES PATIENT-REPORTED OUTCOMES IN MODERATE TO SEVERELY ACTIVE MTX-IR AND TNFi-IR RHEUMATOID ARTHRITIS PATIENTS UP TO 106 WEEKS (RESULTS FROM THE OPEN-LABEL EXTENSION OF PHASE III RANDOMIZED CLINICAL TRIALS)	Sofia Kuzkina	Received

635-POS	Reliability of Elementary Ultrasonographic Lesions in Psoriatic Arthritis and Development of an Atlas: Results of the ECHO-APACHE Study	sandrine jousse-joulin	Received

636-POS	Ultrasound characterisation of cholinergic synovitis before and after hydroxyzine treatment and factors associated with better response.	Carlos Guillen Astete	Received

637-POS	Prevalence and predictors of myocardial edema and myocardial fibrosis determined by cardiac magnetic resonance imaging (cMRI) in Thai patients with systemic sclerosis (SSc)	Suparaporn Wangkaew	Received

639-POS	Factors related to clinical efficacy and infectious adverse events in 450 patients with rheumatoid arthritis treated with JAK inhibitors - Study in the rheumatoid arthritis cohort FIT-RA -	Masahiro Konishi	Received

641-POS	Relationship of diabetic status with cartilage thickness and cartilage composition in study participants with and without osteoarthritis - a matched-pairs design study	Felix Eckstein	Received

661-POS	Fibroblast activation detected by FAPI-PET/CT as a sign of impending RA	Koray Tascilar	Received

666-POS	Immune-Targeted Glucocorticoid ADC for the Treatment of Autoimmune and Inflammatory Diseases	Matthew McClure	Received

671-POS	Cardiac Biomarkers and Prediction of Major Cardiovascular Events in Rheumatoid Arthritis: Results from the ESPOIR Cohort	Jérme Avouac	Received

672-POS	A Head-to-Head Comparison of TNF-a Inhibitors as the First Biologic Treatment for Rheumatoid Arthritis	Amir Aamodt Kazemi	Received

674-POS	Differential Pharmacodynamic Changes of Circulated Immune Subsets After Treatment With Abatacept or Adalimumab in Patients With ACPA Early RA in the AMPLIFIED Study	Stephanie Wolfe	Received

676-POS	Red Flags raising suspicion of Eosinophilic Granulomatosis with Polyangiitis (EGPA): results from the European EGPAware Delphi study	Marta Barragán	Received

678-POS	A machine learning model for the early identification of rheumatoid arthritis: development and validation	Michael Dreyfuss	Received

682-POS	Mycophenolate mofetil versus azathioprine for remission maintenance in microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective study using J-CANVAS registry.	Yuji Kukida	Received

685-POS	The impact of social frailty and physical function on laughter frequency in rheumatoid arthritis patients from a multicenter observational study (T-FLAG)	Mochihito Suzuki	Received

688-POS	Efficacy of ozoralizumab based on baseline RF titres in patients with RA: A post hoc analysis of the OHZORA trial	Shunsuke Okamoto	Received

692-POS	Anti-Gut-Microbiota Serum Reactivity in Preclinical Stages of Rheumatoid Arthritis	Benot GILBERT	Received

694-POS	Dissecting the Genetic and Functional Association of CARD9 with Axial Spondyloarthritis	Félicie Costantino	Received

697-POS	EGL-003: an optimized IL-2 mutein designed to expand regulatory T cells for the treatment of autoimmune diseases	Bernard Vanhove	Received

717-POS	Validation of Anti-14-3-3? (eta) Multiplex Laboratory Developed Test (LDT) for the Diagnosis of Axial Spondyloarthritis (axSpA)	Stephen Bleakley	Received

720-POS	MAPK-kinase mutations and aortic lesions are associated with the distribution of circulating monocytes in histiocytosis.	Guillaume Brenac	Received

727-POS	Lipid Abnormalities and Cardiovascular Outcomes Associated with Baricitinib, Upadacitinib and Tofacitinib in Rheumatoid Arthritis Patients: A Systematic Literature Review and Meta-analysis	Timothy Sexton	Received

728-POS	Deciphering Synovial Fluid Immune Dysregulation in Rheumatoid Arthritis through Cytokine Profiling and Single-Cell Transcriptomics	Manon Lesturgie-Talarek	Received

730-POS	Initial Gut Permeability and bacterial translocation levels predict five-year sacroiliac radiographic progression in axial spondyloarthritis: findings from the DESIR cohort	Frank Verhoeven	Received

734-POS	DAPIROLIZUMAB PEGOL DEMONSTRATED SIGNIFICANT IMPROVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY: EFFICACY AND SAFETY RESULTS OF A PHASE 3 TRIAL	Patrick Cox	Received

739-POS	Plasma Metabolomics and Incident Major Adverse Cardiovascular Events in Patients with Rheumatoid Arthritis	Brittany Weber	Received

750-POS	From Implementation to Impact: GoTreatIT Software Enhances Treat-to-Target Outcomes in Rheumatoid Arthritis	Piotr Kuszmiersz	Received

755-POS	Exploring the differential effects of HLA-B27 and biological sex on clinical characteristics, inflammatory burden, and service utilisation in axSpA to improve service delivery and reduce delay to diagnosis in axSpA	Helena Marzo-Ortega	Received

765-POS	Reality of tocilizumab discontinuation in patients with giant cell arteritis: a routine care study in four French hospitals	Albane Vanlemmens	Received

767-POS	Achieving Remission and Low Disease Activity with Belimumab Versus Placebo in Patients with SLE Excluding the Glucocorticoid Component from Target Definitions: A Post Hoc Analysis of Five Phase 3 Trials	Heather Dowling	Received

769-POS	Ranking of Countries Based on Key Outcomes in Axial Spondyloarthritis. Results from the IMAS study	Marco Garrido-Cumbrera	Received

773-POS	Low Uveitis Rates in Patients with Axial Spondyloarthritis or Psoriatic Arthritis Treated with Bimekizumab: Long-Term Results from Phase 2b/3 Trials	Costello Medical	Received

787-POS	Bimekizumab Demonstrated Similar Efficacy and Safety in Two Clinical Endotypes of Axial Spondyloarthritis: 1-Year Results from Two Phase 3 Trials	Costello Medical	Received

788-POS	Bimekizumab Demonstrated Sustained Efficacy and Safety Across the Full Spectrum of Axial Spondyloarthritis: 3-Year Results from Two Phase 3 Studies and Their Open-Label Extension	Costello Medical	Received

790-POS	Alterations and Clinical Significance of Phospholipid-derived Polyunsaturated Fatty Acids Lipidomes in Patients with Systemic Lupus Erythematosus	You-Jung Ha	Received

791-POS	Soluble checkpoint molecules as predictive biomarker for disease activity and long-term outcome in SLE	Léa-Sophie Dreveton	Received

794-POS	The oral IRAK4-Inhibitors Zabedosertib (BAY1834845) and BAY1830839 suppress immune complex induced interferon-a production by plasmacytoid dendritic cells in a dose dependent manner	Stefan Jodl	Received

806-POS	Plasma membrane antibodies in the pathogenesis of lupus myocarditis	Christy Hess	Received

808-POS	A Generative AI-powered Chatbot for Patient Support and Education in Rare Diseases	David ORegan	Received

820-POS	Is 2 Better Than 1 A Comparative Study of Rhupus and SLE Outcomes: A Retrospective Cohort Analysis	Justin Riley Lam	Received

831-POS	Total Hip and Knee Arthroplasty in Psoriatic Arthritis: Comprehensive Evaluation from a Prospective Study.	Stephen Batter	Received

838-POS	Referrals To Dedicated Psoriatic Disease Triage Clinic Result In Similar Rate Of Newly Diagnosed Psoriatic Arthritis, Irrespective Of Referral Route	Katya Meridor	Received

841-POS	The Renal Activity Index for Lupus Identifies and Predicts Complete Renal Remission or Absence of Kidney Involvement in Systemic Lupus Erythematosus	Guillermo Javier Pons Estel	Received

848-POS	Real-world clinical characteristics and patterns of care in adults with Sjögrens disease diagnosed by rheumatologists vs non-rheumatologists: Retrospective analysis of US electronic health records	Ksenija Brotto	Received

853-POS	Descriptive study of dietary and physical activity habits within a cohort of patients with systemic lupus erythematosus	Noémie Gensous	Received

855-POS	Which biomarker to predict response to a targeted therapy or to monitor disease activity in polymyalgia rheumatica	Guillermo Carvajal Alegria	Received

864-POS	Achievement of Remission Defined by Absence of Objective Signs of Inflammation versus ASDAS Inactive Disease in Patients with Active Axial Spondyloarthritis Treated with Bimekizumab: 52-Week Results from Two Phase 3 Trials	Costello Medical	Received

867-POS	Machine learning model outperforms conventional logistic regression in predicting spinal radiographic progression over 2-year intervals in axial spondyloarthritis	Imke Redeker	Received

868-POS	Clinical Outcomes Of Patients Within The Rheumatoid Arthritis Care Pathway Cohort At a Tertiary Care Integrated Delivery Network: A Comparison To Usual Care	Tarun Sharma	Received

884-POS	Negative pain forecasting through increased catastrophizing impairs everyday functionality in axial spondyloarthritis patients.	Mateusz Wilk	Received

885-POS	Understanding the Rheumatology Unstructured EHR Clinical Notes: A Comparative Analysis of Natural Language Processing Topic Modelling Techniques	Helena Borrell Paños	Received

886-POS	Widespread Pain in Patients with Axial Spondyloarthritis. Results from the IMAS study	Marco Garrido-Cumbrera	Received

893-POS	Efficacy of Secukinumab Across the Axial Spondyloarthritis Spectrum Among Patients Grouped by Age (=40 Years vs 40): A Post Hoc Analysis of 6 Phase 3 Trials	Ksenija Brotto	Received

896-POS	Confounding by Indication in Observational Studies Investigating Glucocorticoid-Associated Adverse Events in Patients with Rheumatoid Arthritis: A Systematic Literature Review	Andriko Palmowski	Received

899-POS	EDUCAR PROJECT: EFFICACY AND IMPLEMENTATION OF A MULTICOMPONENT STRATEGY TO IMPROVE THERAPEUTIC ADHERENCE IN RHEUMATOID ARTHRITIS.	María Ahijón Lana	Received

900-POS	Bimekizumab Maintained Stringent Clinical Responses Over 2 Years in Patients with Axial Spondyloarthritis: Results from Two Phase 3 Studies	Costello Medical	Received

901-POS	Can synovial fluid features be used to predict synovial tissue pathotype	Bella Mehta	Received

905-POS	Early meaningful improvements in spinal pain and correlation with other clinical outcomes in patients treated with filgotinib for radiographic axial spondyloarthritis: A post hoc analysis of the Phase 2 TORTUGA trial	Ilona Swiatkowska	Received

917-POS	Assessment of Pharmacokinetic and Pharmacodynamic Drug-Drug Interactions with Nipocalimab and Relevance to Patients with Rheumatic Diseases	An Vermeulen	Received

920-POS	Bimekizumab Demonstrates Comparable One-Year Efficacy in Male and Female Patients with AxialSpondyloarthritis: Results from Two Phase 3 Studies	Costello Medical	Received

921-POS	Sustained Improvements with Bimekizumab in Pain, Morning Stiffness, Fatigue, Physical Function and Health-Related Quality of Life in Patients with Axial Spondyloarthritis: 3-Year Results from Two Phase 3 Studies	Costello Medical	Received

923-POS	Trends in remission rates for rheumatoid arthritis in England and Wales: a population-level cohort study	Edward Alveyn	Received

926-POS	Fine-tuning and pre-training improve the predictive accuracy of large language models for assessing rheumatoid arthritis disease activity	Suguru Honda	Received

934-POS	Anti-carbamylated fibrinogen response in rheumatoid arthritis is associated with a more severe structural prognosis (ESPOIR cohort)	Pauline BREVET	Received

936-POS	Strategies for Early Rheumatoid Arthritis Management in Resource-Limited Settings	Sipho Ntshalintshali	Received

942-POS	Quantifying the prevalence of disorders of gut brain interaction in systemic sclerosis	Kate Seaton	Received

945-POS	Defining clinical phenotypes of gastrointestinal disease in systemic sclerosis by factor analysis	Laura Ross	Received

949-POS	Elevated serum MMP-3 levels above 300 ng/mL are a clue to distinguish PMR-mimicking LORA from true PMR	Takeshi Suzuki	Received

989-POS	Ambispective, multicenter registry of treatment with anifrolumab in real life in patients with systemic lupus erythematosus from Spanish Rheumatology Departments (ANIFRO-Reu): Efficacy and safety at 3- and 6-month follow-up visits	TAREK CARLOS SALMAN MONTE	Received

990-POS	GCA-PMR Spectrum Disease International Delphi Survey: first iteration indicates consensus	Muhammad Khurshid	Received

1000-POS	Barriers to biological treatment in patients with systemic lupus erythematosus: Results from a real-world survey in Europe and the United States of America	Emily Goddard	Received

1003-POS	INHIBITORY EFFECTS OF DAPIROLIZUMAB PEGOL, A MONOVALENT ANTI-CD40L PEG-CONJUGATED ANTIGEN-BINDING FRAGMENT LACKING AN FC DOMAIN, ON IN VITRO T FOLLICULAR HELPER/B CELL INTERACTIONS AND CYTOKINE PRODUCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS	Patrick Cox	Received

1013-POS	Retinoic acid-related orphan receptor-a as an upstream regulator of Hippo signaling and a therapeutic target in fibrotic tissue remodeling	Cuong Tran-Manh	Received

1015-POS	ASOPAN and ASIF: a new collaboration to raise awareness and to provide better support to axSpA patients in Latin America	Jo Lowe	Received

1016-POS	Embedding a consumer-driven approach into Australian arthritis research: guidance from a national multi-stage consultation	David Liew	Received

1018-POS	Treat-to-target (TTT) management of RMDs: do we know enough How can we make sure we equally participate in the shared decision making process with our HCPs.	Nadia Malliou	Received

1030-POS	Advancing the case for timely weight loss trials in psoriatic disease by better understanding differences in body composition.	Lyn Ferguson	Received

1041-POS	Comparing JAK Inhibitors and Standard Therapies in Refractory Myopathies: Impact on Cardiovascular, Malignancy, and Disease Activity Outcomes	Hanieh Akbari	Received

1053-POS	Ultrasonographic findings in the sesamoid fibrocartilage in patients with recent-onset psoriatic arthritis.	Carlos Guillen Astete	Received

1058-POS	Discordant Pain Patterns in Rheumatoid Arthritis Patients Achieving Inflammatory Control: Analysis of Clinical Trial Data from 7 Randomized Controlled Trials	Andreas Kerschbaumer	Received

1060-POS	Gaps in Training and Expertise in Myositis Outcome Measures: Insights from the 2024 MCTC Investigators Survey.	Shiri Keret	Received

1063-POS	Ulviprubart Pharmacokinetics, Pharmacodynamics (PK/PD), and Safety: Phase 1 Study Results in Patients With Inclusion Body Myositis (IBM)	Paris Fossa	Received

1064-POS	Correlations of CK Changes with Outcome Measures in Myositis: Subgroup differences.	Shiri Keret&8236;&8207;	Received

1083-POS	AUTOINFLAMMATORY DISEASES IN ADULT PATIENTS. SPANISH REGISTRY	eztizen labrador-sánchez	Received

1099-POS	Pain and associated symptoms in Systemic sclerosis: what characteristics and impact on quality of life Are there correlations to clinical and biological features	Sandrine Carvès	Received

1100-POS	A systematic review investigating the rate of adrenal insufficiency after protocolised steroid regimens	Jonathan Bowley	Received

1105-POS	Gender Disparities in cardiovascular outcomes among patients with Sarcoid Myocarditis: A retrospective cohort study	Justin Riley Lam	Received

1106-POS	Racial Disparities in Cardiovascular Outcomes Among Patients with Sarcoid Myocarditis: A Retrospective Cohort Study.	Justin Riley Lam	Received

1113-POS	Treatment of severe systemic sclerosis with blinatumomab, a bispecific anti-CD3/CD19 T cell engager	Christina Gebhardt	Received

1115-POS	VEXAS and non-VEXAS clonal haematopoiesis: determining joint involvement	Pauline Brevet	Received

1116-POS	VEXAS Syndrome in Rheumatology: 47 Cases from VEXASSER Study Group	Paula García-Escudero	Received

1124-POS	Development of a Consensus Definition of VEXAS Flare for Use in Clinical Research	Kathleen York	Received

1137-POS	Genetically proxied glucose-lowering drug target and risk of immune mediated inflammatory disease: a drug target mendelian randomization study	Dongze Wu	Received

1141-POS	CND106, a novel BCMA-directed T-cell engager (TCE), has a differentiated safety profile and potential for development in autoantibody-driven autoimmune diseases	Jamie Haddon	Received

1142-POS	Enhanced type I Interferon signature in pAPS patients with thrombocytopenia	Sophie Charlotte Scholz	Received

1144-POS	Examining Gender Disparities in Pulmonary and Lymph Node Sarcoidosis: Differences in Diagnosis, Treatment, and Clinical Outcomes	Kinga Grzybowski	Received

1147-POS	Can you be cured by the power of your mind?	Nanna Bacci Hartz	Received

1149-POS	Optimizing a physiotherapist-led vocational intervention for people with rheumatoid arthritis and axial spondyloarthritis. A qualitative evaluation of its process and outcomes from the patients perspective	Marloes Voorneveld	Received

1151-POS	Immunogenicity and immune alterations in patients with Systemic Lupus Erythematosus (SLE) after receiving SARS-CoV-2 mRNA-based vaccines	Preeti D	Received

1152-POS	Variations in Chronic Refractory Gout Management between Rheumatologists and Nephrologists	bhavisha desai	Received

1153-POS	Safety and Efficacy of Monthly Dosing of Pegloticase (Every 4 Weeks) With Methotrexate Co-administration in Patients With Uncontrolled Gout: Phase 4 FORWARD Open-label Trial	Brian LaMoreaux	Received

1155-POS	IMPROVEMENT OF FATIGUE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH DAPIROLIZUMAB PEGOL: 48-WEEK RESULTS FROM A PHASE 3 TRIAL	Patrick Cox	Received

1156-POS	Factors associated with time to diagnosis of axial spondyloarthritis in a UK population. A cross-sectional observational study	Yeliz Prior	Received

1174-POS	Elevated prevalence of Trypanosoma cruzi infection in patients with psoriasis and psoriatic arthritis undergoing immunosuppressive therapy: a cross-sectional study	LICIA MOTA	Received

1178-POS	Drug Discontinuation in Inflammatory Arthritis Following Mandatory Non-Medical Switching from Originator to Biosimilar in Quebec, Canada	Autumn Neville	Received

1183-POS	Cross-sectional Study of the Prevalence of Burnout among Irish Rheumatology Consultants, Specialists Registrars, Registrars, Advanced Nurse Practitioners and Clinical Nurse Specialists.	Eleanor Connolly	Received

1188-POS	Prospective analysis of immunoglobulin levels in patients with rheumatic inflammatory diseases treated with interleukin-6 pathway inhibitors.	Elisabet Perea	Received

1190-POS	Mortality Rates and Causes of Death Among Patients With Systemic Lupus Erythematosus The FORWARD Lupus Registry	Minjee Park	Received

1193-POS	Use of premedication with Methylprednisolone for prevention of Acute Phase Reaction Syndrome (APRS) in patients under treatment with Zoledronic Acid during admission for osteoporotic fracture in a FLS	María Isabel Prado Carpintero	Received

1202-POS	Anifrolumab in systemic lupus erythematosus: Real-world efficacy data from the RELES registry inception cohort	IVAN CUSACOVICH	Received

1205-POS	Burden of fatigue in Hypophosphatasia: findings from an observational study in a Tertiary Care Hospital in the United Kingdom	Afzal Latheef	Received

1207-POS	Current practices of diagnosis, treatment, monitoring, and outcomes of ARD-ILD patients: an international, multi-center, retrospective, cohort study	Xavier Teitsma	Received

1209-POS	Effects of CD19 CAR T-cell therapy on quality of life and direct health care costs in systemic lupus erythematosus	Jule Taubmann	Received

1211-POS	Assessing Gout Risk Associated with GLP-1 Therapy in Obese Patients with Type 2 Diabetes: A Retrospective Cohort Study	Justin Riley Lam	Received

1216-POS	Effect of Gender and Follow-up Time in Damage Accrual: Data from a Latin America Lupus Cohort	Guillermo Javier Pons Estel	Received

1222-POS	A District General Hospital Experience Of Biologic Therapy For Patients With Inflammatory Arthritis And Spondyloarthropathies	Harriett Johnson	Received

1224-POS	Consensus-based guidance for glucocorticoid tapering in patients with systemic lupus erythematosus: results from a modified Delphi consensus project	Jacek Walczynski	Received

1228-POS	Cardiovascular and Mortality Outcomes in Psoriatic Arthritis Patients Treated with Hydroxychloroquine: A 10-Year Retrospective Analysis	Hanieh Akbari	Received

1232-POS	Impact of GLP-1 Receptor Agonists on Major Adverse Cardiovascular Events in Ankylosing Spondylitis: A Retrospective Cohort Study	Bal Subedi	Received

1242-POS	Influenza, pneumococcal and herpes zoster vaccination coverage in Australian patients commencing a biologic or targeted synthetic disease modifying anti-rheumatic drug for inflammatory arthritis	Peter Wong	Received

1244-POS	Patients still having flares after 5 years of urate lowering therapy have higher levels of ultrasound detected crystal deposition; results from the NOR-Gout study	Hilde Berner Hammer	Received

1245-POS	Progression of CPPD burden in a cohort of patients with CPPD disease: 1 year follow up	Georgios Filippou	Received

1246-POS	The doctor-patient relationship from the patients perspective insights from the Living with Lupus in 2024 Survey Programme	Zoe Karakikla Mitsakou	Received

1247-POS	Hierarchical analysis for identification of clinical phenotypes of calcium pyrophosphate deposition disease	Silvia Sirotti	Received

1251-POS	Mixed connective tissue disease: a real-world diagnostic phenotype	Luana Gabriela Stanciu	Received

1254-POS	The impact of Multimorbidity on Hospitalization Outcomes in Rheumatoid Arthritis Patients	ghizlane ghoullam	Received

1257-POS	INHIBITION OF RADIOGRAPHIC PROGRESSION WITH BIMEKIZUMAB TREATMENT OBSERVED IN BDMARD-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AT 2 YEARS: RESULTS FROM A PHASE 3 STUDY AND ITS OPEN-LABEL EXTENSION	Bethan Taylor	Received

1262-POS	Screening for osteoporosis in patients with inflammatory bowel diseases.	sebastien ottaviani	Received

1266-POS	Factors associated with efficacy and safety of Anakinra for the treatment of acute crystals related arthritis.	Camille Moriot	Received

1269-POS	EULAR Points to Consider for the Definitions of Difficult-to-Manage and Treatment-Refractory Psoriatic arthritis	Helena Marzo-Ortega	Received

1270-POS	Trends in Gout Incidence, Prevalence, DALY and Death Rates and its association with CKD incidence and prevalence in the United States from 1990 to 2021: A Comprehensive Analysis of State-Level Disparities.	Aishwarya Sudheer	Received

1271-POS	Enhancing Patient Care and Clinical Capacity in Inflammatory Arthritis with an Integrated Electronic Patient-Reported Outcome System	Antoni Chan	Received

1277-POS	Automated ultrasound system assessment - an important adjunct to the clinical evaluation of hands of patients with arthralgia	Marcin Szkudlarek	Received

1294-POS	BIMEKIZUMAB, A DUAL INHIBITOR OF IL-17A AND IL-17F, DEMONSTRATED LONG-TERM SAFETY AND EFFICACY IN BIOLOGIC DMARD-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: FINAL 3-YEAR RESULTS FROM THE PHASE 3 BE OPTIMAL STUDY AND ITS OPEN-LABEL EXTENSION	Bethan Taylor	Received

1295-POS	Circulating Factor VIII as a predictor of clinical activity, phenotype and outcomes in IgG4-related disease	Anne Beenken	Received

1299-POS	Ultrasound joint, tendon and entheseal inflammation in cancer patients who develop arthritis or arthralgia after exposure to immune checkpoint inhibitors: results of a multi-national cohort study	Andrea Di Matteo	Received

1307-POS	Sustained Efficacy of Pozdeutinurad (AR882): Long-Term Treatment Effect of a Novel and Selective URAT1 Inhibitor in Patients with Chronic Gouty Arthritis	Robert Keenan	Received

1316-POS	Three systemic lupus erythematosus phenotypes according to cluster analysis of clinical and immunological classification criteria: A multicentre study of 773 patients	Andrés González	Received

1321-POS	Atrioventricular conduction in chronic inflammatory arthritis: enhanced assessment by new electrocardiographic parameters.	Riccardo Accioli	Received

1323-POS	SGLT2 Inhibitors Do Not Increase the Risk of Urinary Tract Infections Regardless of Immunosuppressive Therapy: An Active Comparator New User Design Using a Real-World Hospital-Based Database in Japan	Hiroshi Tsushima	Received

1326-POS	Adherence to EULAR 2021 vaccination recommendations in a paediatric rheumatology clinic	Michela Agius	Received

1333-POS	From Onset to Insights: Longitudinal Assessment of Disease Activity, Flares, and Damage Accrual in Patients with SLE Across 5 Registries in the Lupus Federated Data Network (LupusNet)	Emma McCarthy	Received

1334-POS	Achievement of Proteinuria Targets =0.4 g/g in Lupus Nephritis: A Post Hoc Analysis of the AURORA 1 Study of Voclosporin	Lucy Hodge	Received

1342-POS	Global pattern, trend, and cross-country inequality of low bone mineral density from 1990 to 2021:findings from the global burden of disease study 2021	Dongze Wu	Received

1347-POS	The Immunomodulatory Role of MIF Signaling Pathway in MDA5 DM	Liqing Ding	Received

1355-POS	CLEARANCE KINETICS AND CARTILAGE RETENTION OF MM-II, A DISPERSION OF LARGE EMPTY LIPOSOMES, IN RAT KNEES	Roni Wechsler	Received

1358-POS	In immune-mediated necrotising myopathy, anti-HMGCR antibodies inhibit HMGCR activity and lead to myopathic lipid droplets accumulation in myofibres	Margherita Giannini	Received

1359-POS	CLUSTERING OF PATIENTS WITH ANTI-SYNTHETASE ANTIBODIES BASED ON SERUM PROTEIN PROFILING	Shintaro Yamamoto	Received

1365-POS	In Vitro and In Vivo Evidence of the Steroid-Sparing Potential of Afimetoran, an Equipotent Toll-Like Receptor 7/8 Dual Antagonist	Stephanie Wolfe	Received

1373-POS	The Integrin Inhibitor Cilengitide Targets CCN1-Mediated Angiogenesis and Reduces Disease Severity in a Preclinical Rheumatoid Arthritis Model	Jérme Avouac	Received

1376-POS	Sputum Calprotectin Levels Do Not Add to Ability of Sputum Anti-CCP and RF to Predict Future Development of RA in Serum Anti-CCP Positive Individuals At-Risk for RA	Kristen Demoruelle	Received

1382-POS	Incidence and Prevalence of Connective Tissue Diseases with Interstitial Lung Disease in the United States	Heather Dowling	Received

1389-POS	A real-world survey of treatment patterns and clinical characteristics for idiopathic inflammatory myopathy patients in Europe and the USA	Jade Garratt-Wheeldon	Received

1392-POS	Presence and Clinical Significance of Anti-SMN Antibodies in Patients with Rheumatic Musculoskeletal Diseases	Yuki Imai	Received

1408-POS	Characterization of Patients with Dermatomyositis and Polymyositis: A Real-World Study using University of Pittsburgh Medical Center (UPMC) IIM Database	Esther Yi	Received

1409-POS	Efficacy of a Novel CXCR7(ACKR3) Agonist In Collagen-Induced Arthritis (CIA) Mouse Model.	Lisa Kim	Received

1416-POS	Gender differences in rheumatoid arthritis: should males with rheumatoid arthritis worry	Tamanna Vinodkumar Mohta	Received

1417-POS	Rheumatoid arthritis and interstitial lung disease in hospitalized patients: A five-year nationwide analysis	Tamanna Vinodkumar Mohta	Received

1425-POS	Mediators of osteopetrosis in miR-146a deficient mice	Elisabeth Simader	Received

1430-POS	Genetic Landscape of Adult-onset Stills Disease with Macrophage Activation Syndrome: Identifying Key Risk Loci for Disease Mechanisms and Personalized Treatment	Yujie Shen	Received

1438-POS	Molecular Pathways Altered in the Hypermobility Spectrum Disorder	Cesar Vidal Elizondo Solis	Received

1439-POS	Poloxamers 188 & 182 are Effective in Repairing the Membrane Resealing Defect in Myositis	Wael Jarjour	Received

1449-POS	Structured patient involvement in rheumatoid arthritis research: Identification and prioritization of key research questions using the James Lind Alliance method	Anna Fryxelius	Received

1452-POS	Sustainment of Improvement in Job-Related Self-Efficacy at 3- and 6- Month Post-Participation: Proof-of-Concept of the Making it Work with Systemic Sclerosis (MiW-SS) Program	Janet L Poole	Received

1453-POS	A scoping review and expert consensus on barriers, enablers, and research gaps to healthy aging Position of the Multidisciplinary International Positive Ageing Group (MIPAG)	Yves Henrotin	Received

1454-POS	Enhancing the Rheumatology Homecare Prescription Process Using Leeds Improvement Methodology	Lynda Bailey	Received

1461-POS	Prevalence and correlates of adherence to disease modifying antirheumatic drugs (DMARDs) in adults with rheumatoid arthritis and its consequences a scoping review	Agnes Kocher	Received

1462-POS	BIOFEEDBACK TRAINING IN THE TREATMENT OF RHEUMATOID ARTHRITIS PATIENTS	Moska Raza	Received

1464-POS	Survey of Current Physiotherapy Services for People with Axial Spondyloarthopathy attending Irish Rheumatology Departments	Karen Quinn	Received

1468-POS	Effectiveness and implementation of DMARD adherence interventions in rheumatoid arthritis: a systematic review	Janette Ribaut	Received

1472-POS	Social Determinants of Health and Disease Activity in Inflammatory Arthritis What Role Does the Area Deprivation Index Play	Kaleb Michaud	Received

1481-POS	Exploring the feasibility of using digital technologies to measure free-living physical activity and real-time symptoms in people living with Rheumatoid Arthritis	Rosalind Baynham	Received

1483-POS	Risk of 90-Day Heart Failure Readmission among Patients with Rheumatoid Arthritis: A Retrospective Cohort Study	Toshio Takano	Received

1486-POS	A scoping review of the evidence base for non-pharmacological management of fatigue across the lifespan of people with musculoskeletal conditions	EMMA DURES	Received

1497-POS	Occupational Therapy management of hand osteoarthritis: current Irish practice in primary and integrated care services	Paula Minchin	Received

1508-POS	Care Gaps in ANCA-Associated Vasculitis (AAV): exploring unmet needs and misalignments between patients and physicians	Jackie Read	Received

EULAR 2025

11-14 June 2025 Barcelona

About us

Search and consult posters online
in an exclusive section
for each poster

ACTIVE FROM 11/06/2025 TO 11/06/2025

Poster
Gallery

Upload
Poster

Featured Poster

Vote poster

Poster Discussion
Forum



		Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.

About us

Terms and Conditions

Special Access

Commercial Web Access